Skip to main content

ZNTL

Zentalis Pharmaceuticals, Inc.
Last price
$3.75
As of

Active signals for ZNTL

Top institutional holders of ZNTL (13F)

FundMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LP$6.9M0.01%+100.9%
RENAISSANCE TECHNOLOGIES LLC$4.5M0.01%-32.8%
RENAISSANCE TECHNOLOGIES LLC$3.9M0.01%+24.0%
RENAISSANCE TECHNOLOGIES LLC$3.5M0.00%,
D. E. Shaw & Co., Inc.$3.5M0.00%-10.6%
MILLENNIUM MANAGEMENT LLC$3M0.00%+91.6%
D. E. Shaw & Co., Inc.$2.2M0.00%+25.2%
TWO SIGMA INVESTMENTS, LP$2.1M0.00%,
D. E. Shaw & Co., Inc.$2M0.00%,
TWO SIGMA INVESTMENTS, LP$2M0.00%+7.9%
MILLENNIUM MANAGEMENT LLC$1.4M0.00%,
MILLENNIUM MANAGEMENT LLC$909K0.00%-25.4%
CITADEL ADVISORS LLC$388K0.00%+771.9%
Point72 Asset Management, L.P.$222K0.00%-5.4%
Point72 Asset Management, L.P.$135K0.00%,
CITADEL ADVISORS LLC$50K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, ZNTL

See more ZNTL signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ZNTL in your watchlist and get notified the moment a new signal fires.

Track ZNTL on Kresmion →